{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:16:07Z","timestamp":1783055767794,"version":"3.54.6"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The diagnosis and management of relapsing peritoneal dialysis-associated peritonitis (PDAP) remains a clinical challenge. This study aimed to\u00a0identify biomarkers associated with relapsing PDAP and discuss potential mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>31 PDAP patients treated in 2023 were prospectively enrolled, including 23 cured patients and 8 with relapsing PDAP. Peritoneal dialysate samples were collected for conventional bacterial culture, 16S rDNA sequencing, and proteomic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The positivity rate for conventional culture was 64.5%, while that for 16S rDNA sequencing was 67.8%; combining both methods increased the detection rate to 83.9%. Microbiome analysis revealed that PDAP relapse may stem not only from exogenous pathogens but also from gut-derived bacterial translocation due to impaired local immunity. Proteomic profiling revealed that compared with the Cured group, the Relapse group showed downregulated levels of CCL28, CD40, and uPA, and upregulated NRTN. Bioinformatic analysis revealed dysregulation in pathways related to inflammation, fibrinolysis, and immune clearance, thus linking relapsing PDAP to a disturbed peritoneal immune microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Relapsing PDAP is linked to peritoneal immune dysregulation, and 16S rDNA sequencing represents a complementary diagnostic tool. These findings may guide precise management and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1810227","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:21:17Z","timestamp":1783052477000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune dysregulation drives the relapse of peritoneal dialysis-associated peritonitis: a single-center prospective study"],"prefix":"10.3389","volume":"17","author":[{"given":"Guang","family":"Yang","sequence":"first","affiliation":[{"name":"Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University","place":["Shenzhen, China"]},{"name":"Shenzhen Clinical Research Center for Urology and Nephrology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingbo","family":"Hong","sequence":"additional","affiliation":[{"name":"Renal Division, Peking University (PKU)-Shenzhen Clinical Institute of Shenzhen University Medical College","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Lai","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuying","family":"Xiong","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University","place":["Shenzhen, China"]},{"name":"Shenzhen Clinical Research Center for Urology and Nephrology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibo","family":"Xiong","sequence":"additional","affiliation":[{"name":"Division of Renal Medicine, Peking University Shenzhen Hospital, Peking University","place":["Shenzhen, China"]},{"name":"Shenzhen Clinical Research Center for Urology and Nephrology","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s404983","article-title":"Long-term effects of severe burns on the kidneys: Research advances and potential therapeutic approaches","volume":"16","author":"Yang","year":"2023","journal-title":"J Inflammation Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000037577","article-title":"Risk factors affecting the sleep quality of patients on dialysis: A single-center cross-sectional study","volume":"103","author":"Peng","year":"2024","journal-title":"Med (Baltimore)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/idr.s442641","article-title":"Evolution of peritoneal dialysis-associated peritonitis: Pathogen, antibiotic resistance, and the impact of lymphocyte count on treatment outcomes","volume":"17","author":"He","year":"2024","journal-title":"Infect Drug Resist"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.18565\/nephrology.2022.4.64-99","article-title":"ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment","volume":"42","author":"Li","year":"2022","journal-title":"Perit Dial Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1177\/08968608231172740","article-title":"ISPD catheter-related infection recommendations: 2023 update","volume":"43","author":"Chow","year":"2023","journal-title":"Perit Dial Int"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/6662488","article-title":"Repeat and relapsing peritonitis microbiological trends and outcomes: A 21-year single-center experience","volume":"2021","author":"Reis","year":"2021","journal-title":"Int J Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3747\/pdi.2016.00147","article-title":"Improved outcome of enteric peritonitis in peritoneal dialysis patients aged 50 years and older with temporary discontinuation of peritoneal dialysis and intravenous meropenem","volume":"37","author":"Abrahams","year":"2017","journal-title":"Perit Dial Int"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/08968608251331894","article-title":"Bacterial biofilm on peritoneal dialysis catheters: A retrospective observational study","volume":"46","author":"Liu","year":"2025","journal-title":"Perit Dial Int"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2215\/cjn.02360213","article-title":"Bacteria-derived DNA fragment in peritoneal dialysis effluent as a predictor of relapsing peritonitis","volume":"8","author":"Szeto","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e41485","article-title":"Post-burns persistent inflammation leads to kidney PANoptosis with caspases pathway activation","volume":"11","author":"Yang","year":"2025","journal-title":"Heliyon"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2004.01.002","article-title":"T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection","volume":"10","author":"Vallejo","year":"2004","journal-title":"Trends Mol Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: Signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2023.11.052","article-title":"Persistent inflammation, immunosuppression, and catabolism syndrome (PICS): a review of definitions, potential therapies, and research priorities","volume":"132","author":"Chadda","year":"2024","journal-title":"Br J Anaesth"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.3mr0821-147r","article-title":"Immunoregulation by type I interferons in the peritoneal cavity","volume":"111","author":"Chuah","year":"2022","journal-title":"J Leukoc Biol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2017.08.012","article-title":"CCL28 chemokine: An anchoring point bridging innate and adaptive immunity","volume":"51","author":"Mohan","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e78206","DOI":"10.7554\/elife.78206","article-title":"CCL28 modulates neutrophil responses during infection with mucosal pathogens","volume":"13","author":"Walker","year":"2024","journal-title":"Elife"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300093","article-title":"Mucosal CCL28 chemokine improves protection against genital herpes through mobilization of antiviral effector memory CCR10+CD44+ CD62L-CD8+ T cells and memory CCR10+B220+CD27+ B cells into the infected vaginal mucosa","volume":"211","author":"Dhanushkodi","year":"2023","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000969","article-title":"The mucosae-associated epithelial chemokine (MEC\/CCL28) modulates immunity in HIV infection","volume":"2","author":"Castelletti","year":"2007","journal-title":"PloS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/itt.s163614","article-title":"Multiple effects of CD40-CD40L axis in immunity against infection and cancer","volume":"7","author":"Ara","year":"2018","journal-title":"Immunotargets Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107709","article-title":"Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint","volume":"219","author":"Tang","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh144","article-title":"CD40 is expressed on rat peritoneal mesothelial cells and upregulates ICAM-1 production","volume":"19","author":"Yang","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"B22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1681\/asn.v124695","article-title":"CD40 is expressed on human peritoneal mesothelial cells and upregulates the production of interleukin-15 and RANTES","volume":"12","author":"Basok","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.05.578900","article-title":"CD40 expression by B cells is required for optimal immunity to murine Pneumocystis infection","volume":"230","author":"Sassi","year":"2024","journal-title":"J Infect Dis"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e0331","DOI":"10.1097\/hc9.0000000000000331","article-title":"A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han population","volume":"7","author":"Wu","year":"2023","journal-title":"Hepatol Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10875-023-01633-1","article-title":"Clinical and immunological features, genetic variants, and outcomes of patients with CD40 deficiency","volume":"44","author":"Banday","year":"2023","journal-title":"J ClinImmunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1593\/neo.10728","article-title":"Activation of urokinase plasminogen activator and its receptor axis is essential for macrophage infiltration in a prostate cancer mouse model","volume":"13","author":"Zhang","year":"2011","journal-title":"Neoplasia"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.1055\/s-0044-1779202","article-title":"A novel plasminogen activator anti-fibrin-uPA increases the sensitivity of the plasmin generation assay to therapeutic target PAI-1","volume":"142","author":"De Simone","year":"2023","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ydbio.2011.07.021","article-title":"Concomitant lack of MMP9 and uPA disturbs physiological tissue remodeling","volume":"358","author":"Lund","year":"2011","journal-title":"Dev Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2013.08.016","article-title":"Urokinase-type plasminogen activator (uPA) modulates monocyte-to-macrophage differentiation and prevents Ox-LDL-induced macrophage apoptosis","volume":"231","author":"Paland","year":"2013","journal-title":"Atherosclerosis"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1004091","article-title":"Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration","volume":"187","author":"Novak","year":"2011","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1086\/431600","article-title":"Urokinase-type plasminogen activator, an endogenous antibiotic","volume":"192","author":"Jin","year":"2005","journal-title":"J Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e202000780","DOI":"10.26508\/lsa.202000780","article-title":"Neurturin regulates the lung-resident macrophage inflammatory response to viral infection","volume":"3","author":"Connolly","year":"2020","journal-title":"Life Sci Alliance"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1402496","article-title":"Neurturin influences inflammatory responses and airway remodeling in different mouse asthma models","volume":"194","author":"Mauffray","year":"2015","journal-title":"J Immunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2015.09.031","article-title":"Therapeutic potential of the endoplasmic reticulum located and secreted CDNF\/MANF family of neurotrophic factors in Parkinson's disease","volume":"589","author":"Voutilainen","year":"2015","journal-title":"FEBS Lett"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2024.07.016","article-title":"Neurturin GF enhances the acute cytokine response of inflamed skin","volume":"145","author":"Jones","year":"2025","journal-title":"J Invest Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/cells9040865","article-title":"Revisiting the role of neurotrophic factors in inflammation","volume":"9","author":"Morel","year":"2020","journal-title":"Cells"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-1319","article-title":"Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca","volume":"44","author":"Song","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001673","article-title":"Increased Th2 cytokine secretion, eosinophilic airway inflammation, and airway hyperresponsiveness in neurturin-deficient mice","volume":"186","author":"Michel","year":"2011","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00933-y","article-title":"Antibiotic perturbations to the gut microbiome","volume":"21","author":"Fishbein","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s44318-026-00796-y","article-title":"Antibiotic-induced gut microbiome dysbiosis: Risks and strategies for mitigation","volume":"45","author":"M\u00fcller","year":"2026","journal-title":"EMBO J"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70168","article-title":"Gut microbiota dysbiosis: Pathogenesis, diseases, prevention, and therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm (2020)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248290","article-title":"CD40 signaling augments IL-10 expression and the tolerogenicity of IL-10-induced regulatory dendritic cells","volume":"16","author":"Dawicki","year":"2021","journal-title":"PloS One"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810227\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:21:19Z","timestamp":1783052479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810227\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2026.1810227"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1810227","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"article-number":"1810227"}}